Targeting Rad51 as a strategy for the treatment of melanoma cells resistant to MAPK pathway inhibition

Makino, Elena; Froehlich, Lisa Marie; Sinnberg, Tobias; Kosnopfel, Corinna; Sauer, Birgit; Garbe, Claus; Schittek, Birgit

dc.contributor.author	Makino, Elena
dc.contributor.author	Froehlich, Lisa Marie
dc.contributor.author	Sinnberg, Tobias
dc.contributor.author	Kosnopfel, Corinna
dc.contributor.author	Sauer, Birgit
dc.contributor.author	Garbe, Claus
dc.contributor.author	Schittek, Birgit
dc.date.accessioned	2020-12-22T11:38:51Z
dc.date.available	2020-12-22T11:38:51Z
dc.date.issued	2020
dc.identifier.issn	2041-4889
dc.identifier.uri	http://hdl.handle.net/10900/110905
dc.language.iso	en	de_DE
dc.publisher	Nature Publishing Group	de_DE
dc.relation.uri	http://dx.doi.org/10.1038/s41419-020-2702-y	de_DE
dc.subject.ddc	570	de_DE
dc.subject.ddc	610	de_DE
dc.title	Targeting Rad51 as a strategy for the treatment of melanoma cells resistant to MAPK pathway inhibition	de_DE
dc.type	Article	de_DE
utue.quellen.id	20200929220116_00670
utue.personen.roh	Makino, Elena
utue.personen.roh	Froehlich, Lisa Marie
utue.personen.roh	Sinnberg, Tobias
utue.personen.roh	Kosnopfel, Corinna
utue.personen.roh	Sauer, Birgit
utue.personen.roh	Garbe, Claus
utue.personen.roh	Schittek, Birgit
dcterms.isPartOf.ZSTitelID	Cell Death & Disease	de_DE
dcterms.isPartOf.ZS-Issue	Article 581	de_DE
dcterms.isPartOf.ZS-Volume	11	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE